Strides Pharma Science Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Profit before tax

2,905.14

69.62

-64.76

21.51

111.64

Net cashflow-operating activity

421.48

-35.76

241.74

-282.69

282.76

Net cash used in investing activity

-137.59

-61.27

-182.58

18.78

-275.64

Netcash used in fin. activity

-370.32

107.62

10.82

250.73

-48.64

Net inc/dec in cash and equivlnt

-86.42

10.60

69.98

-13.18

-41.52

Cash and equivalnt begin of year

92.75

82.11

12.12

25.30

66.82

Cash and equivalnt end of year

6.33

92.71

82.11

12.12

25.30